APA (7th ed.) Citation

EM, E., AB, A., HA, A. D., M, J., SSH, S., A, S., . . . GE, E. (2026). Nanoliposomal myricetin attenuates diabetic testicular tissue injury and cellular dysfunction via coordinated modulation of PI3K/AKT/mTOR/SREBP-1c, Nrf2/HO-1, NF-κB, and caspase signaling pathways. Tissue & cell, 102, 103608. https://doi.org/10.1016/j.tice.2026.103608

Chicago Style (17th ed.) Citation

EM, Elmorsy, Al-Ghafari AB, Al Doghaither HA, Jan M, Shah SSH, Syed A, Marghani BH, and Elshopakey GE. "Nanoliposomal Myricetin Attenuates Diabetic Testicular Tissue Injury and Cellular Dysfunction via Coordinated Modulation of PI3K/AKT/mTOR/SREBP-1c, Nrf2/HO-1, NF-κB, and Caspase Signaling Pathways." Tissue & Cell 102 (2026): 103608. https://doi.org/10.1016/j.tice.2026.103608.

MLA (9th ed.) Citation

EM, Elmorsy, et al. "Nanoliposomal Myricetin Attenuates Diabetic Testicular Tissue Injury and Cellular Dysfunction via Coordinated Modulation of PI3K/AKT/mTOR/SREBP-1c, Nrf2/HO-1, NF-κB, and Caspase Signaling Pathways." Tissue & Cell, vol. 102, 2026, p. 103608, https://doi.org/10.1016/j.tice.2026.103608.